Sarah Blagden

Oncology Scientific Advisory Board

Sarah trained as a doctor in London before undertaking her Medical Oncology specialist training in Cambridge and the Royal Marsden Hospital. In 2003 she completed a PhD at Cambridge University in fruit fly genetics followed by a Clinical Fellowship at the Institute of Cancer Research’s Drug Development Unit.

From 2006-2015, Sarah was a Senior Lecturer at Imperial College London and led their Early Cancer Trials Unit. In 2015 she moved to the University of Oxford where she is now Professor of Medical Oncology, Director of Oncology Clinical Trials Office (OCTO), lead for Oxford Early Cancer Medicine Centre (ECMC) and runs a molecular biology laboratory exploring protein synthesis in cancer.

Sarah has been chief or principal investigator for a number of national and international cancer studies. She has worked with the MHRA/NICE to develop guidance for their new pathways to approval and advises biotechnology and pharmaceutical companies on cancer drug development.

Get started with us today

Discover what’s possible when you have the right partner. Get in touch to see how we can support you.

Other board members

Got a question? Get in Touch or Submit an RFI/RFP


Our team is on hand to answer any questions you might have relating to the work we do at Simbec-Orion. Just fill in the form below, making sure to tick the boxes that apply, and we’ll respond as quickly as we can.

Looking to volunteer for a clinical trial?

Visit our dedicated volunteer website here, or email [email protected]

Follow us on Social Media

Send us a message, we’ll respond as quickly as possible

Complete the form below, and we’ll get back to you as soon as possible regarding your query.

Name(Required)
Opt In Emails